Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500

Benzinga11/01 03:23

Companies Like Nurix Therapeutics (NASDAQ:NRIX) Are In A Position To Invest In Growth

Simply Wall St10/31 19:24

Nurix Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire10/31 19:00

UBS Launches SMID Cap Biotechs With Cancer, Autoimmunity in Focus

Seeking Alpha10/25 03:32

UBS Initiates Coverage On Nurix Therapeutics With Buy Rating, Announces Price Target of $35

Benzinga10/24 19:46

Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit

GlobeNewswire10/22 04:00